Ticker Scorecard - VERA Basics Company: Vera Therapeutics, Inc. IPO Date: May 14, 2021 Sector: Healthcare Industry: Biotech Market Cap: $1.81B Activated in VL: True Average Daily Range Avg Daily Range: $0.78 | 3.53% Avg Daily Range (30 D): $0.99 | 2.83% Avg Daily Range (90 D): $1.00 | 2.44% Institutional Daily Volume Avg Daily Volume: .38M Avg Daily Volume (30 D): .86M Avg Daily Volume (90 D): .71M Trade Size Avg Trade Size (Sh.): 73 Avg Trade Size (Sh.) (30 D): 64 Avg Trade Size (Sh.) (90 D): 63 Institutional Trades Total Inst.Trades: 1,192 Avg Inst. Trade: $2.3M Avg Inst. Trade (30 D): $1.66M Avg Inst. Trade (90 D): $2.15M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.43M Avg Closing Trade (30 D): $2.7M Avg Closing Trade (90 D): $3.36M Avg Closing Volume: 110.81K     News Dec 9, 2024 @ 11:29 PM Vera Therapeutics Reports Inducement Grants Under ... Source: N/A Oct 28, 2024 @ 9:37 PM Vera Therapeutics Announces Proposed Public Offeri... Source: N/A Oct 26, 2024 @ 11:30 PM Vera Therapeutics Announces 96-week eGFR Stabiliza... Source: N/A Jul 5, 2024 @ 8:31 PM Vera Therapeutics Reports Inducement Grants Under ... Source: N/A Jun 11, 2024 @ 8:01 PM Vera Therapeutics Appoints Christy J. Oliger to Bo... Source: Vera Therapeutics Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.61 $-.85 $-.62 Diluted EPS $-2.61 $-.85 $-.62 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -134.38M $ -46.63M $ -33.71M Operating Income / Loss $ -145.28M $ -49.8M $ -37.34M Cost of Revenue $ $ $ Net Cash Flow $ -.19M $ 2.17M $ -44.02M PE Ratio